[1]
|
TORRE LA,BRAY F,SIEGEL RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87. |
[2]
|
ZHENG R,ZENG H,ZHANG S,et al.National estimates of cancer prevalence in China,2011[J].Cancer Lett,2015,370(1):33. |
[3]
|
RAMALINGAM SS,OWONIKOKO TK,KHURI FR.Lung cancer:new biological insights and recent therapeutic advances[J].CA Cancer J Clin,2011,61(2):91. |
[4]
|
ZHANG S,CUI B,LAI H,et al.Ovarian cancer stem cells express ROR1,which can be targeted for anti-cancer-stem-cell therapy[J].Proc Natl Acad Sci U S A,2014,111(48):17266. |
[5]
|
KIM IG,LEE JH,KIM SY,et al.Fibulin-3 negatively regulates ALDH1 via c-MET suppression and increase c-radiation-induced sensitivity in some pancreatic cancer cell lines[J].Biochem Biophy Res Commun,2014,454(3):369. |
[6]
|
ZHAO D,MO Y,LI MT,et al.NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells[J].J Clin Invest,2014,124(12):5453. |
[7]
|
DRUESNE-PECOLLO N,TEHARD B,MALLET Y,et al.Alcohol and genetic polymorphisms:effect on risk of alcohol-related cancer[J].Lancet Oncol,2009,10(2):173. |
[8]
|
MIRANTI CK.Controlling cell surface dynamics and signaling:how CD82/KAI1 suppresses metastasis[J].Cell Signal,2009,21(2):1961. |
[9]
|
武世伍,承泽农,俞岚,等.CD82/KAI1和HIF-1α在非小细胞肺癌中的表达及其与血管生成拟态的关系[J].中国肺癌杂志,2011,14(2):918. |
[10]
|
GINESTIER C,HUR MH,CHARAFE-JAUFFRET E,et al.ALDH 1 is a marker of normal and malignant human mammary stem cells and a proctor of poor clinical outcome[J].Cell Stem Cell,2007,1(5):555. |
[11]
|
AYUB TH,KEWER-PAIK MD,DEBALD M,et al.Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer[J].Oncotarget,2015,6(18):16437. |
[12]
|
CAO YT,LI JH,WANG YT,et al.Serum ALDHA1 is a tumor marker for the diagnosis of non-small cell lung cancer[J].Tumori,2014,100(2):214. |
[13]
|
TAKEDA T,HATTORI N,TOKUHARA T,et al.Adenoviral transduction of MRP-1/CD9 and KAI-1/CD82 inhibits lymph node metastasis in orthotropic lung cancer model[J].Cancer Res,2007,67(4):17449. |
[14]
|
WANG G,JIANG H,XU H,et al.Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma[J].Oncol Lett,2015,9(4):1681. |
[15]
|
ZHOU L,YU L,WU SW,et al.Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer[J].World J Surg Oncol,2015,13:324. |
[16]
|
张震寰,吴礼高,武世伍.KAI1/CD82在喉鳞状细胞癌中的表达及其临床意义[J].蚌埠医学院学报,2012,37(8):930. |
[17]
|
SCHNEIDER M,HUBER J,HADASCHIK B,et al.Characterization of colon cancer cells:a functional approach characterizing CD133 as a potential stem cell marker[J].BMC Cancer,2012,12:96. |